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Abstract
Background: Patients with chronic fatigue syndrome typically report high levels of physical activity
before becoming ill. Few studies have examined premorbid and current activity levels in chronically
fatigued patients.
Methods: In a case-control study, 33 patients with chronic, unexplained, disabling fatigue attending
a university-based clinic specializing in fatigue were compared to 33 healthy, age- and sex-matched
controls. Patients rated their activity levels before their illness and currently, using scales designed
for this purpose. Controls reported their level of activity of 2 years previously and currently. Chi-
square analyses, Student's t tests, and Wilcoxon signed rank tests were used in pair matched
analyses.
Results: Compared to healthy controls, patients with chronic, unexplained fatigue rated
themselves as more active before their illness (p ≤ 0.001) and less active currently (p ≤ 0.001). The
patients also reported they currently stood or walked less than the controls (median [inter-quartile
range] = 4 [2-5] versus 9 [7.5–12] hours, p ≤ 0.001), and spent more time reclining (median [inter-
quartile range] = 12 [10-16] versus 8 [8–9.5] hours, p ≤ 0.001). These differences remained
significant for the subset of patients who met strict criteria for chronic fatigue syndrome or
fibromyalgia.
Conclusion: Patients with chronic, unexplained, disabling fatigue reported being more active
before becoming ill than healthy controls. This finding could be explained by greater premorbid
activity levels that could predispose to illness, or by an overestimation of previous activity. Either
possibility could influence patients' perceptions of their current activity levels and their judgments
of recovery. Perceived activity should be addressed as part of management of the illness.
Background
Chronic, unexplained, disabling fatigue is reported by up
to 2.6 per cent of patients seeking health care [1]. Chronic
fatigue syndrome (CFS) is a more narrowly defined illness
with prominent fatigue and at least 4 associated symp-
toms [2]. Many CFS patients also suffer from fibromyalgia
[3], a disabling condition characterized by chronic wide-
spread pain, fatigue, and sleep disturbances [4]. Individu-
als with CFS often perceive physical activity as more of an
effort than healthy people [5], underestimate their cogni-
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tive and physical abilities [5-9], and are more aware of,
and focused on, their internal physiological state [7,9,10].
Furthermore, CFS patients aspire to greater activity levels
[6], and rate themselves as having been significantly more
active [6] and "action-prone" before they became ill, than
do control subjects [11]; "action-proneness" also
increases with treatment [12]. The high levels of physical
activity reported by patients have been corroborated by
their spouses, partners, or parents [13].
The etiology of chronic, unexplained fatigue, CFS, and
fibromyalgia remains unclear [7], but recent work sug-
gests that these disorders may involve enhanced intero-
ception [14,15]. Interoception is the perception of
internal sensory phenomena, especially visceral percep-
tions [16]. The biological underpinnings of interoception
are only now being explored, but intriguing neuroimaging
studies suggest that a discrete interoceptive cortex, the
anterior insula, modulates this phenomenon [17]. If inte-
roception were altered in chronically fatigued individuals,
this could affect their internal perception and, conse-
quently, their perceived ability and capacity.
To replicate previous findings and extend them to well-
defined subgroups, we conducted a clinic-based, case-
control study of fatigued patients, a large majority of
whom suffered from CFS and/or fibromyalgia. We com-
pared self-reported premorbid and current activity levels
of the patients and their healthy controls to address the
following questions: 1) Do patients with chronic, unex-
plained, disabling fatigue, including the subsets with CFS
and fibromyalgia, perceive their premorbid activity levels
as higher than the current activity levels perceived by
healthy matched controls? 2) Do patients with chronic,
unexplained, disabling fatigue, including the subsets with
CFS and fibromyalgia, perceive their current activity levels
as lower than those perceived by healthy matched con-
trols?
Methods
Subjects and Setting
Patients were adults evaluated in a university-based refer-
ral clinic for chronic fatigue and pain. The clinic accepts
both self- and physician-referred patients; individuals
were not required to meet case definitions for either CFS
or fibromyalgia to be evaluated. Patients underwent an
intake evaluation that included a standardized physical
examination, medical history, questionnaire on past and
current symptoms, screening laboratory tests, and a struc-
tured psychiatric interview. A lay interviewer administered
the National Institutes of Mental Health Diagnostic Inter-
view Schedule Version III-A [18], a structured interview
that assigns current and lifetime psychiatric diagnoses
based on criteria established in the Diagnostic and Statisti-
cal Manual of Mental Disorders, 3rded. (Revised) [19] for
somatization disorder, panic disorder, generalized anxiety
disorder, major depression, dysthymia, and alcohol
abuse/dependence. CFS and fibromyalgia were diagnosed
according to the guidelines of the Centers for Disease
Control and Prevention [20] and the American College of
Rheumatology [4], respectively. Those who did not meet
the CFS case definition met the criteria for idiopathic
chronic fatigue [20]. Fibromyalgia often co-occurred with
idiopathic, chronic fatigue and CFS, as previously
described [3].
To recruit controls, we asked patients the following: "We
would like to compare the activity levels of people with
chronic fatigue to healthy people. If you have a healthy
friend who would agree to complete [questions about
activity] only, please fill out the information below. If
possible, pick someone who is similar to you in terms of
sex and age." In this way, 33 controls were recruited. The
University of Washington Human Subjects Office
reviewed and approved all clinic procedures and consent
forms.
Measures
The questionnaire for this study was mailed along with an
annual clinic newsletter. Non-responders were mailed the
questionnaire a second time, followed by an attempt to
gather the information by telephone. The questionnaire
contained 4 items specifically asking about levels of activ-
ity [see Additional file 1]. Patients were asked to rate their
typical levels of activity prior to becoming chronically
fatigued and compare it to an average healthy person by
using a 10-point scale (1 = extremely low to 10 =
extremely high). Using the same scale, patients were also
asked to rate their typical level of activity during the previ-
ous 7 days as compared to that of an average healthy per-
son [see Additional file 1]. The other 2 items inquired
about activity during the previous 24 hours. One
instructed patients to estimate how many hours they had
spent standing or walking, sitting, or reclining or lying
down. The other asked if this level of activity was higher,
lower, or average compared to their recent activity levels.
For the healthy controls, the first of the 4 activity ques-
tions was revised to ask about their activity as of 2 years
ago compared to the average healthy person. The two-year
recall period was chosen because the mean fatigue dura-
tion reported by patients evaluated in the clinic was nearly
2 years. The remaining 3 questions were identical to those
given to patients. No other information was collected
from the control subjects.
Statistical Analyses
Respondents were classified as patients or their friends
(i.e., controls). To examine between-group differences,
chi-square analyses were used for dichotomous variables
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and interval variables were compared by using Student's t
test when data were normally distributed, and by using
Wilcoxon signed rank tests when data were not normally
distributed, always using pair-related comparisons.
Results
Demographic and Clinical Characteristics
Overall, 462 of 678 (68%) consecutively evaluated clinic
patients completed the questionnaire. Of these 462, 44
patients had a friend who completed the 4 activity items;
these 44 patients and their friends constituted the study
sample. The 44 patients tended to be older than the larger
clinic population (43.6 vs. 39.6 years, p = 0.02), but did
not differ in gender (84% vs. 74% female), marital status
(50% vs. 50% married), duration of fatigue (5.9 vs. 5.2
years), or proportion diagnosed with CFS (57% vs. 56%)
or fibromyalgia (21% vs. 23%). Likewise, our study sam-
ple had rates similar to those of all clinic patients for life-
time diagnoses of alcohol abuse (14% vs. 16%), major
depression (69% vs. 65%), dysthymic disorder (26% vs.
22%), generalized anxiety disorder (17% vs. 24%), panic
disorder (26% vs. 19%), and somatization disorder (29%
vs. 21%). However, they tended to be diagnosed more
often with melancholic depression (11% vs. 5%, p =
0.02).
Of the 44 fatigued clinic patients, we limited our analysis
to the 33 who met criteria for CFS, idiopathic chronic
fatigue, and/or fibromyalgia. The other 11 patients were
excluded for medical or psychiatric conditions that could
explain their fatigue [21]. The demographic and clinical
characteristics of the 33 patients and their 33 matched
controls are presented in Table 1. Patients and controls
did not differ in age (p = 0.22) or sex (p = 0.50). Of the 33
patients with chronic, unexplained, debilitating fatigue,
25 (76%) met the criteria for CFS, 7 (21%) met the criteria
for idiopathic chronic fatigue, and 9 (27%) met criteria
for fibromyalgia. Only 1 had fibromyalgia alone, without
CFS or idiopathic chronic fatigue.
Table 2 illustrates that, compared with their matched con-
trols, the 33 patients rated themselves as more active
before the onset of illness (Z score -3.05, p = 0.002) and
less active currently (Z score -4.72, p < 0.001). More spe-
cifically, in the previous 24 hours, patients reported stand-
ing or walking 5 hours less than their healthy friends (Z
score -4.39, p < 0.001) and lying or reclining 4 hours more
(Z score -4.29, p < 0.001), with no differences in the time
spent sitting (Z score -0.86, p = 0.39). For both patients
and controls, the activity reported during the previous 24
hours represented a typical day (Z score -1.12, p = 0.26).
Lastly, we considered premorbid and current activity lev-
els in the CFS and fibromyalgia subgroups. These results
are not displayed in the table. The median rating (and
interquartile range) for premorbid activity level was 9 (8 –
9.5) among the 25 CFS patients versus 8 (7 – 9) among
controls (Z = -2.18, p = 0.03). Among CFS patients, the
median rating (and interquartile range) for current activ-
ity was 3 (2 – 5) versus 8 (6.5 – 8.5) among controls (Z =
-4.23, p ≤ 0.001). In the 9 patients with fibromyalgia, the
median rating (and interquartile range) for premorbid
activity was 9 (8 – 9.5) versus 8 (7 – 8.5) among controls
(Z = -2.46, p = 0.01), and the current activity was lower: 4
(1.5 – 4.5) versus 7 (6 – 8) (Z = -2.53, p = 0.01).
Discussions and Conclusion
We have confirmed the previous finding that patients with
CFS report higher levels of premorbid activity than do
healthy control subjects, and we have extended this find-
ing to include patients with chronic, unexplained fatigue
and fibromyalgia. As expected, both CFS and fibromyalgia
patients reported less current activity than healthy con-
trols, but small sample sizes and Bonferroni's corrections
resulted in borderline significance for some of the sub-
group comparisons. Our findings are congruent with
those of 3 retrospective studies reporting that CFS patients
perceived themselves as more active before their illness
began than healthy controls [6,11,21]. In contrast, the
only prospective cohort study of risk factors for CFS found
that sedentary behavior at 10 years of age doubled the risk
of self-reported CFS in adulthood [22]. Since no prospec-
tive data exist on the actual pre-morbid activity levels of
individuals who later suffer a fatiguing illness, it is unclear
Table 1: Demographic and clinical characteristics of patients and healthy control subjects
Characteristic Patients Controls
Demographic
Number 33 33
Age, mean years (SD) 45.6 (11.8) 44.1 (13.1)
Female, n (%) 26 (79) 28 (85)
Clinical
CFS criteria met, n (%) 25 (76) ---
Idiopathic chronic fatigue criteria met n (%) 7 (21)
Fibromyalgia criteria met 1, n (%) 9 (27) ---
1 1 patient had fibromyalgia, but neither CFS nor idiopathic chronic fatigue.
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whether our data reflect pre-morbid excessive activity, or
alternatively, illness-related alterations in the perception
or recall of premorbid activity.
One of the "altered-perception" hypotheses involves sen-
sitized interoception. CFS and fibromyalgia have been
postulated to be central nervous system hypersensitivity
disorders, characterized by enhanced or sensitized intero-
ception [15,23,24]. A central nervous system hypersensi-
tivity disorder would be consistent with patients' reports
of disturbed cognition and concentration and sensitivity
to exercise, chemicals, and odors [5,7-9,25]. Support for
this explanation comes from investigations that have
described discrepancies between subjectively reported
impairments and objective measures of activity [26,27],
effort with exercise [5,28,29], sleep quantity and quality
[30], and cognitive symptoms and cognitive abilities
[8,9,25,29].
Of interest, humans appear to have a distinct cortical
image of homeostatic afferent activity that reflects all
aspects of the physiological condition of all tissues of the
body. This interoceptive system is linked to the auto-
nomic nervous system, but is distinct from the exterocep-
tive system that reflects somatic motor activity. The
primary interoceptive representation in the anterior insula
cortex engenders distinct bodily sensations, including
pain, temperature, itch, sensual touch, muscular and vis-
ceral sensations, and vasomotor activity [31]. Neuroimag-
ing studies relevant to interoception and the feeling of self
are rapidly accumulating and underscore the biological
underpinnings of this phenomenon [16,17].
Lastly, perception and consequent ability, as well as exter-
nal agents, may influence patients' beliefs. For example,
when benign chemicals were given blindly to people with
CFS and multiple chemical sensitivities, individuals who
Table 2: Previous and current activity levels of patients and healthy control subjects
Characteristic Patients Controls
Previous activity level1,2, median (IQR) 3 9 (8 – 9.5) 8 (6.5 – 8.5)*
Previous activity level, n (%)
Level 1 0 0
Level 2 0 0
Level 3 0 1 (3)
Level 4 1 (3) 1 (3)
Level 5 0 2 (6)
Level 6 1 (3) 4 (12)
Level 7 3 (9) 5 (15)
Level 8 8 (24) 12 (36)
Level 9 12 (36) 5 (15)
Level 10 8 (24) 3 (9)
Last week's activity2, median (IQR) 3 3 (2 – 5) 8 (6 – 8) †
Last week's activity, n (%)
Level 1 5 (15) 0
Level 2 6 (18) 0
Level 3 7 (21) 1 (3)
Level 4 4 (12) 2 (6)
Level 5 5 (15) 3 (9)
Level 6 3 (9) 4 (12)
Level 7 1 (3) 5 (15)
Level 8 2 (6) 11 (33)
Level 9 0 4 (12)
Level 10 0 3 (9)
Last 24 hours' activities, median hours (IQR)3
Standing or walking 4 (2 – 5) 9 (7.5 – 12) †
Sitting 6 (5 – 9) 6 (4 – 8)
Reclining or lying down 12 (10 – 16) 8 (8 – 9.5) †
Activity Level in Last 24 Hours, %4
Higher than recently 6 24
Lower than recently 45 27
Average 49 48
1 premorbid activity level for patients, activity level 2 years ago for friends; 2 rated from 1 (extremely low) to 10 (extremely high); 3 interquartile 
range; 4 compared to recent levels.
*p ≤ 0.01; † p ≤ 0.001
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believed they were getting the chemical performed poorly
on cognitive tests, whereas cognitive function did not dif-
fer between those who received the chemicals and those
who did not [25]. In another investigation, fatigued peo-
ple and CFS patients had greater doubts about actions and
more concerns over mistakes than controls [32,33]. Such
self-critical personality traits might diminish judgments of
current abilities and exaggerate previous abilities.
This study has several limitations. First, our sample was
drawn from consecutive patients evaluated at a referral
clinic. Because patients who present to specialty clinics
probably differ from community samples or those drawn
from primary care clinics on important variables [34], our
results may not be generalizable to other settings or other
fatigued patients. Second, because our measures were
obtained at only one time point, we do not know if these
activity levels represent sustained or transitory levels. Sim-
ilarly, to minimize the burden on the control subjects, we
did not ask them to provide detailed demographic infor-
mation. Third, our measures of activity were brief and not
validated against actigraphy or even the report of the
friends, and therefore are subject to the usual biases asso-
ciated with self-reported health-related behavior, includ-
ing the propensity to over-value pre-illness functioning.
Fourth, we could not verify objectively that the selected
friend was actually healthy, yet the presence of chronic
conditions would decrease the differences between groups
and thus render our findings less significant. Lastly, only
a small fraction of the total clinic population obtained
data from a friend. The small sample that we examined,
however, was similar in most respects to the larger clinic
population.
In conclusion, we have replicated previous work showing
that CFS patients report greater premorbid activity levels
than healthy controls, and we have extended these obser-
vations to more rigorously defined fatiguing conditions.
These findings suggest that at this point clinical manage-
ment should address both perceptions of symptoms as
well as actual activity levels. Cognitive behavior therapy
and graded exercise programs are designed to change both
dimensions, and have been shown to be efficacious treat-
ments for the majority of adult, ambulant CFS patients
[35,36]. Other innovative interventions that can be easily
implemented and are acceptable to patients are also
needed.
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